INGRESAR
CREAR CUENTA
Artículos
Registro de la asociación y los mecanismos involucrados | 27 MAR 23

Detección de hipovitaminosis D en pacientes con hipertensión arterial

El objetivo del estudio fue evaluar el déficit de vitamina D (medida como 25OH vitamina D en plasma), en pacientes con diagnóstico de HTA.
50
Autor/a: Arriola Mariano Tomas; Riccobelli Nicolas; Govone Rodigo; Garcia Vasquez Fortunato; Luna Octavio y otros. 
INDICE:  1. Texto principal | 2. Texto principal
Texto principal
  1. Clifford J. Rosen, M.D. Vitamin D Insufficiency. N Engl J Med 2011;364:248-54.
  2. van Schoor NM, Visser M, Pluijm SM, y col. Vitamin D deficiency as a risk factor for osteoporotic fractures. Bone 2008;42:260-6
  3. Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003;326:469
  4. Ginde A, Scragg R, Schwartz RS, y col. Prospective study 12 of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older US adults. J Am Geriatr Soc 2009;57:1595-603
  5. Oparil S, Acelajado MC, Bakris GL, Berlowitz DR, y cols. Hypertension. Nat Rev Dis Primers. 2018 Mar 22;4:18014. doi: 10.1038/nrdp.2018.14
  6. www.indec.gob.ar
  7. Nair, R.; Maseeh, A. Vitamin D: The “sunshine” vitamin. J. Pharm. Pharm. 2012, 3, 118–126.
  8. Gallagher J C; Sai A; Templin T, y col. Dose Response to Vitamin D Supplementation in  Postmenopausal Women. A Randomized Trial. Ann Intern Med. 2012;156:425-437
  9. Holick, M.F.; Binkley, N.C.; Bischo_-y col. Evaluation, Treatment, and Prevention of Vitamin D Deficiency: An Endocrine Society ClinicalPractice Guideline. J. Clin. Endocrinol. Metab. 2011, 96, 1911–1930.
  10. Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease and osteoporosis. Am J Clin Nutr 2004; 79: 362-71
  11. Puche R. SOBRE LA PREVALENCIA DE HIPOVITAMINOSIS D EN ARGENTINA. MEDICINA (Buenos Aires) 2015; 75: 183-186
  12. Lind L, Hanni A, Lithell H, y col. Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens. 1995;8:894 –901
  13. Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, Ethnicity, and Blood Pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens 2007; 20:713–719
  14. Forman, J.P.; Giovannucci, E.; Holmes, MD.; y col.Plasma 25-Hydroxyvitamin D Levels and Risk of Incident Hypertension. Hypertension 2007, 49, 1063–1069.
  15. Kunutsor, S.K.; Apekey, T.A.; Steur, M. Vitamin D and risk of future hypertension: Meta-analysis of 283,53participants. Eur. J. Epidemiol. 2013, 28, 205–221.
  16. Li YC, Kong J, Wei M, y col. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002;110:229 –238
  17. Goel RK, Lal H. Role of vitamin D supplementation in hypertension.Indian J Clin Biochem. 2011; 26:88–90
  18. Sheikh V, Mozaianimonfared A, Gharakhani M, y col. Effect of vitamin D supplementation versus placebo on essential hypertension in patients with vitamin D deficiency:a double-blind randomized clinical trial. J Clin Hypertens. 2020; 00:1–7.
  19. Witham MD, Dove FJ, Dryburgh M, y col.: The effect of different doses of vitamin D3 on markers of vascular health in patients with type 2 diabetes:A randomised controlled trial. Diabetologia. 2010; 53(10): 2112–9.
  20. Farapti F, Fadilla C, Yogiswara N, y col. Effects of vitamin D supplementation on 25(OH)Dconcentrations and blood pressure in the elderly: a systematic review and meta-analysis [version 3; peer review: 2approved] F1000Research 2020, 9:633
  21. https://www.saha.org.ar/formacion/guias-y-consensos
  22. Bouillon, R. Comparative analysis of nutritional guidelines for vitamin D. Nat. Rev. Endocrinol. 13, 466–479 (2017)
  23. Lips, P. et al. Current vitamin D status in European and Middle East countries and strategies to prevent vitamin D deficiency; a position statement of the European Calcified Tissue Society. Eur. J. Endocrinol. 180, 23–54 (2019)
  24. Alfredsson L ,  Armstrong BK , Butterfield DA, y cols. Insufficient Sun Exposure Has Become a Real Public Health Problem. Int. J. Environ. Res. Public Health 2020, 17, 5014; doi:10.3390/ijerph17145014
  25. Adamczak ,  Surma S,  Więcek A. Vitamin D and Arterial Hypertension: Facts and Myths. Current Hypertension Reports (2020) 22:57
  26. Wang TJ; Pencina MJ; Booth SL.Vitamin D Deficiency and Risk of Cardiovascular Disease. Circulation. 2008;117:503-511
  27. Witham MD, Dove FJ, Khan F y col. Effects of Vitamin D supplementation on markers of vascular function after myocardial infarction—A randomised controlled trial. International Journal of Cardiology Marzo 2012
  28. Wang H, Xia N, Yang Y y col. Influence of vitamin D supplementation on plasma lipid profiles: A meta-analysis of randomized controlled trials. Lipids in Health and Disease 2012, 11:42
  29. Pittas AG, Lau J, Hu FB, y col. The role of vitamin D and calcium in type 2 diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab 2007;92:2017-29
  30. Pittas AG, Harris SS, Stark PC, y col. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in non diabetic adults. Diabetes Care 2007;30:980-6
  31. Giovannucci E, Liu Y, Hollis BW, y col. 25-Hydroxyvitamin D and risk of myocardial infarction in men. Arch Intern Med 2008;168:1174-80
  32. Poole KE, Loveridge N, Barker PJ, y col. Reduced vitamin D in acute stroke. Stroke. 2006;37:243–245
  33. Yin L
« Página anterior
 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

» Centro de Atención IntraMed
AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024